Fly News Breaks for June 12, 2019
Jun 12, 2019 | 11:15 EDT
Cantor Fitzgerald analyst Louise Chen lowered her price target for Neos Therapeutics to $10 from $20, driven by multiple contraction, given increasing headwinds from macro factors. The analyst reiterates an Overweight rating on the shares.
News For NEOS From the Last 2 Days
There are no results for your query NEOS